Anti-tumor DNA vaccines based on the expression of human papillomavirus-16 E6/E7 oncoproteins genetically fused with the glycoprotein D from herpes simplex virus-1.
DNA vaccines encoding the human papillomavirus type-16 (HPV-16) E6 and E7 oncoproteins genetically fused to the human herpes simplex virus type 1 (HSV-1) gD protein were tested in mice for induction of T cell-mediated immunity and protection against tumor cell challenge. Hybrid genes, generated afte...
Main Authors: | Lasaro, M, Diniz, M, Reyes-Sandoval, A, Ertl, H, Ferreira, L |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2005
|
Similar Items
-
Enhanced anti-tumor effect of a gene gun-delivered DNA vaccine encoding the human papillomavirus type 16 oncoproteins genetically fused to the herpes simplex virus glycoprotein D
by: M.O. Diniz, et al.
Published: (2011-05-01) -
Localisation of human papillomavirus 16 E7 oncoprotein changes with cell confluence.
by: Joanna Laurson, et al.
Published: (2011-01-01) -
Fused toes homolog, a potential molecular regulator of human papillomavirus type 16 E6 and E7 oncoproteins in cervical cancer.
by: Prabakaran D S, et al.
Published: (2022-01-01) -
Fused toes homolog, a potential molecular regulator of human papillomavirus type 16 E6 and E7 oncoproteins in cervical cancer
by: Prabakaran D. S., et al.
Published: (2022-01-01) -
Intrabodies targeting human papillomavirus 16 E6 and E7 oncoproteins for therapy of established HPV-associated tumors
by: Francesca Paolini, et al.
Published: (2021-01-01)